Genetic Signatures Announces Strategic Partnership with Integrated Gulf Biosystems for Expanded Market Reach in the Middle East
23 August 2023
Genetic Signatures, a leading innovator in molecular diagnostics, is pleased to announce a new channel partner in the Middle East, Integrated Gulf Biosystems (IGB). With IGB’s headquarters in Dubai, the exclusive agreement allows Genetic Signatures to tap into the promising market of United Arab Emirates, Kingdom of Saudi Arabia, Bahrain and Qatar. This partnership is a significant step forward in Genetic Signatures’ mission to expand its market presence in the Middle East, providing clinical diagnostic laboratories access to its patented 3base® technology, and syndromic testing solutions for infectious diseases.
Leveraging IGB’s extensive expertise with Genetic Signatures’ current OEM partners and bolstered by their in-house technical assistance and training capabilities, IGB is poised to seamlessly introduce Genetic Signatures to their established customer networks.
“The collaboration with Integrated Gulf Biosystems marks an exciting chapter as we extend our molecular diagnostic solutions to the Middle East. Their well-established network, expertise, and dedication to quality closely align with our mission of enhancing patient outcomes through innovative diagnostics. This partnership grants clinical laboratories in the region access to our proprietary 3base® technology and syndromic solutions for a wide range of infectious diseases, and reinforces Genetic Signatures’ commitment to expand our global presence in Europe and the Middle East,” said Dr John Melki, CEO and Director, Genetic Signatures.
“Our association with Genetic Signatures, is aligned with their mission to deliver the most advanced applications for molecular diagnostic screening assays. Genetic Signatures will provide highly multiplexed real-time PCR screening assays, for the diagnosis of a variety of infectious diseases. IGB, being an end-to-end solution provider for automated workflows in the region, with the association with Genetic Signatures for the Middle East region will be a great asset, for our foray into serving the Clinical Genetics and diagnostics area, thereby helping to deliver faster and accurate patient results,” said Prabhu Sampath, Co-Founder and CEO, Integrated Gulf Biosystems LLC.
This collaboration presents exciting opportunities for Genetic Signatures and IGB, which is expected to bring increased brand visibility and sales in the region. Moreover, this collaboration will provide invaluable local insights and support in the Middle East.
